Marcia P. Belvin
2023
In 2023, Marcia P. Belvin earned a total compensation of $1.2M as Senior Vice President, and Chief Scientific Officer at CytomX Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Option Awards | $169,270 |
| Salary | $459,827 |
| Stock Awards | $402,250 |
| Other | $5,000 |
| Total | $1,206,347 |
Belvin received $459.8K in salary, accounting for 38% of the total pay in 2023.
Belvin also received $170K in non-equity incentive plan, $169.3K in option awards, $402.3K in stock awards and $5K in other compensation.
Rankings
In 2023, Marcia P. Belvin's compensation ranked 998th out of 2,907 executives tracked by ExecPay. In other words, Belvin earned more than 65.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 998 out of 2,907 | 66th |
Division Manufacturing | 601 out of 1,599 | 62nd |
Major group Chemicals And Allied Products | 413 out of 901 | 54th |
Industry group Drugs | 402 out of 864 | 54th |
Industry Pharmaceutical Preparations | 275 out of 622 | 56th |
Source: SEC filing on April 4, 2024.
Belvin's colleagues
We found two more compensation records of executives who worked with Marcia P. Belvin at CytomX Therapeutics in 2023.